The Zhitong Finance App learned that Bank of America Securities released a research report stating that total revenue/net profit attributable to Shiyao Group (01093.HK) increased by 40.1% and 139.2% year-on-year, respectively, to 18.6 billion yuan/6.1 billion yuan. In the second quarter alone, total revenue increased 93.8% year over year to RMB 12.1 billion. Net profit due increased 389.3% year over year to RMB 5.2 billion. The bank raised its estimated net profit for 2026-28 by 1.9%, 2.6% and 1.6%, respectively. The target price was raised from HK$7.6 to HK$8.6, but since the main drug Enbip (NBP) faced price reduction pressure, it reaffirmed its “outperforming the market” rating.

The Zhitong Finance App learned that Bank of America Securities released a research report stating that total revenue/net profit attributable to Shiyao Group (01093.HK) increased by 40.1% and 139.2% year-on-year, respectively, to 18.6 billion yuan/6.1 billion yuan. In the second quarter alone, total revenue increased 93.8% year over year to RMB 12.1 billion. Net profit due increased 389.3% year over year to RMB 5.2 billion. The bank raised its estimated net profit for 2026-28 by 1.9%, 2.6% and 1.6%, respectively. The target price was raised from HK$7.6 to HK$8.6, but since the main drug Enbip (NBP) faced price reduction pressure, it reaffirmed its “outperforming the market” rating.